Performance Evaluation of a Non-Invasive Glucose Monitor as Compared to CGM Data Acquired by the iPro2
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01831752|
Recruitment Status : Completed
First Posted : April 15, 2013
Last Update Posted : November 18, 2014
|Condition or disease|
|Type 1 Diabetes|
|Study Type :||Observational|
|Actual Enrollment :||9 participants|
|Official Title:||Performance Evaluation of a Non-Invasive Glucose Monitor (Spectral Data Acquisition) as Compared to CGM Data Acquired by the iPro2|
|Study Start Date :||February 2013|
|Actual Primary Completion Date :||June 2014|
|Actual Study Completion Date :||June 2014|
Type 1 Diabetes Melitus
Subjects aged 12 through 75, previously diagnosed with type 1 diabetes mellitus, currently using insulin to treat their diabetes.
- blood glucose correlation coefficient [ Time Frame: Up to 16 weeks ]To generate a non-invasive blood glucose measurement with continuous glucose monitor data and alternate site data.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01831752
|United States, California|
|Sansum Diabetes Research Institute|
|Santa Barbara, California, United States, 93105|
|Principal Investigator:||Howard Zisser, MD||Sansum Diabetes Research Institute|